E. Orfanoudaki

发表

E. Kalaitzakis, E. Orfanoudaki, A. Machaira, 2021 .

EUS Evaluation of Pancreatic Cystic Lesions

E. Kalaitzakis, E. Orfanoudaki, A. Machaira, 2021 .

Buried Bumper Syndrome: A common complication of levodopa intestinal infusion for Parkinson disease.

E. Athanasakis, C. Spanaki, M. Koulentaki, 2021, Parkinsonism & related disorders.

The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn’s Disease With Poor Prognostic Factors: The MODIFY Study

K. Katsanos, D. Christodoulou, A. Ilias, 2021, Crohn's & colitis 360.

Keeping on the High Quality of Health Care in Greek Inflammatory Bowel Disease Patients in the SARS-CoV-2 Era

I. Koutroubakis, K. Foteinogiannopoulou, E. Orfanoudaki, 2020, Clinical Gastroenterology and Hepatology.

Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease.

I. Koutroubakis, E. Theodoraki, K. Foteinogiannopoulou, 2018, Inflammatory bowel diseases.

Active smoking is associated with the development of adverse events of biological therapy in patients with inflammatory bowel disease.

I. Koutroubakis, E. Theodoraki, K. Foteinogiannopoulou, 2022, European journal of gastroenterology & hepatology.

Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with inflammatory bowel disease

M. Gazouli, I. Koutroubakis, E. Theodoraki, 2022, International Journal of Colorectal Disease.

Pyoderma gangrenosum associated with chronic refractory pouchitis: a case successfully treated with infliximab

I. Koutroubakis, K. Krasagakis, D. Koumaki, 2020, Annals of gastroenterology.

Effects of Doxycycline, Metronidazole and their Combination on Candida species Colonization of the Human Oropharynx, Intestinal Lumen and Vagina

Y. Tselentis, G. Samonis, S. Maraki, 2003, Journal of chemotherapy.

Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab

M. Gazouli, I. Koutroubakis, E. Theodoraki, 2019, European journal of gastroenterology & hepatology.

Hysteroscopy in women with implantation failures after in vitro fertilization: findings and effect on subsequent pregnancy rates.

D. Stathis, D. Hassiakos, K. Pantos, 2009, Journal of minimally invasive gynecology.

Mucocutaneous manifestations in patients with inflammatory bowel disease: a decade study from a Greek cohort

I. Koutroubakis, M. Stefanidou, K. Krasagakis, 2021, European journal of gastroenterology & hepatology.

Use of vedolizumab in a patient with chronic and refractory pouchitis

I. Koutroubakis, K. Foteinogiannopoulou, E. Orfanoudaki, 2018, Annals of gastroenterology.

Peripheral primitive neuroectodermal tumour during pregnancy.

J. Damilakis, G. Samonis, H. Varveris, 2002, The British journal of radiology.

Letter to the Editor: Is There a Role for Switching Infliximab in Order to Regain Anti-TNF Response in Cases With Active Inflammatory Bowel Disease?

I. Koutroubakis, E. Orfanoudaki, A. Mantaka, 2019, Inflammatory Bowel Diseases.

Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease

I. Koutroubakis, E. Theodoraki, K. Foteinogiannopoulou, 2023, Journal of clinical medicine.

Letter: is there a role for infliximab biosimilar in patients with inflammatory bowel disease with secondary loss of response to infliximab innovator?

I. Koutroubakis, I. Drygiannakis, E. Orfanoudaki, 2018, Alimentary pharmacology & therapeutics.

Clinical Value of Proactive Infliximab Drug Monitoring in Patients With Inflammatory Bowel Disease.

I. Koutroubakis, E. Theodoraki, K. Foteinogiannopoulou, 2020, Inflammatory bowel diseases.

Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry

C. Liatsos, N. Kyriakos, G. Bamias, 2022, Inflammatory bowel diseases.

Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease

C. Liatsos, G. Bamias, I. Koutroubakis, 2022, Journal of clinical medicine.

Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey

J. Gisbert, B. Barberio, G. Fiorino, 2022, Journal of Crohn's & colitis.

Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative?

E. Kouroumalis, D. Sifaki-Pistolla, E. Orfanoudaki, 2019, Annals of gastroenterology.

Real-life utility and diagnostic accuracy of a home-performed fecal calprotectin test to predict endoscopic activity in patients with inflammatory bowel disease under maintenance treatment with adalimumab

I. Koutroubakis, E. Theodoraki, I. Drygiannakis, 2021, European journal of gastroenterology & hepatology.

Effect of golimumab on health-related quality of life, other patient-reported outcomes and healthcare resource utilization in patients with moderate-to-severe ulcerative colitis: a real-world multicenter, noninterventional, observational study in Greece

K. Katsanos, D. Christodoulou, O. Giouleme, 2021, European journal of gastroenterology & hepatology.

Osteoclast: like giant cell undiferrentiated pancreatic tumor diagnosed by means of EUS guided FNA

E. Kalaitzakis, I. Koutroubakis, E. Lappa, 2021, Acta bio-medica : Atenei Parmensis.

Immunoproliferative Small Intestinal Disease in a Liver Transplant Recipient: A Case Report and Literature Review

I. Goulis, D. Samonakis, A. Iliadis, 2021, Experimental and Clinical Transplantation.

Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?

M. Gazouli, I. Koutroubakis, E. Theodoraki, 2020, Intestinal research.